✦ LIBER ✦

A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients

✍ Scribed by M. Siebels; K. Rohrmann; R. Oberneder; M. Stahler; N. Haseke; J. Beck; R. Hofmann; M. Kindler; P. Kloepfer; C. Stief

Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 311 KB
Volume: 29
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s00345-010-0570-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of 5-fluorouracil, folin

A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma

✍ Ronald M. Bukowski; Go Inoshita; Prasad Yalavarthi; Siva Murthy; Vicki Gibson; G 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 2 views

Phase I and II trials of subcutaneously

Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma

✍ T. Olencki; D. Peereboom; L. Wood; G. T. Budd; A. Novick; J. Finke; D. McLain; P 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 103 KB

A phase I clinical trial of low-dose int

A phase I clinical trial of low-dose interferon-α-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma

✍ Robert J. Amato; Muhammad Khan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 221 KB

A Phase II trial of intravenous gemcitab

A Phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-α in patients with metastatic renal cell carcinoma

✍ Christopher W. Ryan; Nicholas J. Vogelzang; Walter M. Stadler 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to determine the response rate and toxicity of gemcitabine and continuous‐infusion 5‐fluorouracil (5‐FU) in combination with subcutaneous interleukin‐2 (IL2) and interferon‐α (IFNA) in patients with metastatic renal cell carcinoma. ## METH

A phase II trial of interleukin-2 by con

A phase II trial of interleukin-2 by continuous infusion and interferon by intramuscular injection in patients with renal cell carcinoma

✍ A. Mittelman; C. Puccio; T. Ahmed; J. Zeffren; A. Choudhury; Z. Arlin 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB 👁 2 views

Clinical and Immunomodulatory Effects of

Clinical and Immunomodulatory Effects of Celecoxib Plus Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients with COX-2 Tumor Immunostaining

✍ Anita Schwandt; Jorge A. Garcia; Paul Elson; Jeanie Wyckhouse; James H. Finke; J 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 189 KB